Literature DB >> 29128062

Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography.

Eugenia Tsai1, Tai-Ping Lee2.   

Abstract

The incidence and prevalence of nonalcoholic fatty liver disease (NAFLD) are increasing and identification of people at risk of disease progression is extremely important. The current gold standard for diagnosing NAFLD/nonalcoholic steatohepatitis (NASH) is by liver biopsy, but it has several limitations. Noninvasive tests via biomarkers and transient elastography to assess NAFLD/NASH are being used in clinical practice. The most validated diagnostic panels include the NAFLD fibrosis score, FIB-4 (Fibrosis-4), and FibroMeter. Transient elastography is very useful in evaluating advanced fibrosis and cirrhosis. Published by Elsevier Inc.

Entities:  

Keywords:  Nonalcoholic fatty liver disease; Noninvasive biomarker; Steatohepatitis; Transient elastography

Mesh：

Substances：

Year:  2018        PMID： 29128062     DOI： 10.1016/j.cld.2017.08.004

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN： 1089-3261            Impact factor:   6.126


  27 in total

1.  Screening for hepatic fibrosis and steatosis in Turkish patients with type 2 diabetes mellitus: A transient elastography study.

Authors:  Meryem Demir; Oğuzhan Deyneli; Yusuf Yılmaz
Journal:  Turk J Gastroenterol       Date:  2019-03       Impact factor: 1.852

2.  Dysregulation of the Splicing Machinery Is Associated to the Development of Nonalcoholic Fatty Liver Disease.

Authors:  Mercedes Del Río-Moreno; Emilia Alors-Pérez; Sandra González-Rubio; Gustavo Ferrín; Oscar Reyes; Manuel Rodríguez-Perálvarez; Marina E Sánchez-Frías; Rafael Sánchez-Sánchez; Sebastián Ventura; José López-Miranda; Rhonda D Kineman; Manuel de la Mata; Justo P Castaño; Manuel D Gahete; Raúl M Luque
Journal:  J Clin Endocrinol Metab       Date:  2019-08-01       Impact factor: 5.958

Review 3.  Nonalcoholic Fatty Liver Disease: An Update on the Diagnosis.

Authors:  Jia-Zhen Zhang; Jing-Jing Cai; Yao Yu; Zhi-Gang She; Hongliang Li
Journal:  Gene Expr       Date:  2019-04-22

4.  Seasonal variability in the activity of common chronic liver diseases.

Authors:  Daniel Iluz-Freundlich; Julia Uhanova; Gerald Y Minuk
Journal:  Can Liver J       Date:  2019-12-10

Review 5.  Advance of Serum Biomarkers and Combined Diagnostic Panels in Nonalcoholic Fatty Liver Disease.

Authors:  Yuping Zeng; He He; Zhenmei An
Journal:  Dis Markers       Date:  2022-06-29       Impact factor: 3.464

6.  The association between dietary inflammation scores and non-alcoholic fatty liver diseases in Iranian adults.

Authors:  Hossein Farhadnejad; Asal Neshatbini Tehrani; Mitra Kazemi Jahromi; Farshad Teymoori; Ebrahim Mokhtari; Ammar Salehi-Sahlabadi; Parvin Mirmiran
Journal:  BMC Gastroenterol       Date:  2022-05-29       Impact factor: 2.847

7.  Comparison of the diagnostic value between triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio in metabolic-associated fatty liver disease patients: a retrospective cross-sectional study.

Authors:  Zhi Liu; He He; Yuzhao Dai; Lidan Yang; Shenling Liao; Zhenmei An; Shuangqing Li
Journal:  Lipids Health Dis       Date:  2022-06-25       Impact factor: 4.315

8.  Predictive factors associated with liver fibrosis and steatosis by transient elastography in patients with HIV mono-infection under long-term combined antiretroviral therapy.

Authors:  Hugo Perazzo; Sandra W Cardoso; Carolyn Yanavich; Estevão P Nunes; Michelle Morata; Nathalia Gorni; Paula Simplicio da Silva; Claudia Cardoso; Cristiane Almeida; Paula Luz; Valdilea G Veloso; Beatriz Grinsztejn
Journal:  J Int AIDS Soc       Date:  2018-11       Impact factor: 5.396

9.  Fibroscan-Based Score to Predict Significant Liver Fibrosis in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease.

Authors:  Wei-Yu Kao; I-Wei Chang; Chi-Long Chen; Chien-Wei Su; Sheng Uei Fang; Jui-Hsiang Tang; Chun-Chao Chang; Yu-Jia Chang; Weu Wang
Journal:  Obes Surg       Date:  2020-04       Impact factor: 4.129

Review 10.  Management of nonalcoholic fatty liver disease in the Middle East.

Authors:  Faisal M Sanai; Faisal Abaalkhail; Fuad Hasan; Muhammad Hamed Farooqi; Nawal Al Nahdi; Zobair M Younossi
Journal:  World J Gastroenterol       Date:  2020-07-07       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.